The Aquatic Animal Drug Approval Partnership Program (AADAP) was established in 1994 following a decision by the U.S. Food and Drug Administration (FDA) that mandated that the use of medications in aquaculture needed to be regulated. The Program’s goal is to ensure continued progress towards obtaining safe and effective new FDA-approved medications for use in Federal, State, Tribal and private aquaculture programs throughout the United States. It is the only program in the U.S. that is fully dedicated to this mission, and program benefits extend to freshwater and marine finfish culture and fisheries management programs nationwide.
An updated version of the Guide to Using Drugs, Biologics, and Other Chemicals in Aquaculture. It describes regulated products (i.e., drugs, biologics, disinfectants, and pesticides) that are approved for use in U.S. aquaculture. This updated version also contains a section on common fish diseases and clinical signs.
Influence of Salinity on Sedation of Sunshine Bass with AQUI-S®20E (10% eugenol)
This latest Drug Research Information Bulletin, DRIB #51, is now available.